Volume 115, Issue 1, Pages (October 2003)

Slides:



Advertisements
Similar presentations
Volume 9, Issue 5, Pages (May 2002)
Advertisements

The Structural Basis for :Phosphopeptide Binding Specificity
The Structure of a Bcl-xL/Bim Fragment Complex
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
A Novel Cofactor for p300 that Regulates the p53 Response
Structure and Protein Design of a Human Platelet Function Inhibitor
Phosphorylation of Cdc20 by Bub1 Provides a Catalytic Mechanism for APC/C Inhibition by the Spindle Checkpoint  Zhanyun Tang, Hongjun Shu, Dilhan Oncel,
The C2 Domain of PKCδ Is a Phosphotyrosine Binding Domain
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 87, Issue 7, Pages (December 1996)
The Structure of the Cytoplasmic Domain of the Chloride Channel ClC-Ka Reveals a Conserved Interaction Interface  Sandra Markovic, Raimund Dutzler  Structure 
Volume 14, Issue 5, Pages (May 2008)
Structure of the Papillomavirus DNA-Tethering Complex E2:Brd4 and a Peptide that Ablates HPV Chromosomal Association  Eric A. Abbate, Christian Voitenleitner,
Volume 10, Issue 2, Pages (August 2002)
Volume 9, Issue 5, Pages (May 2002)
Volume 115, Issue 2, Pages (October 2003)
Volume 64, Issue 3, Pages (November 2016)
The Structure of a Bcl-xL/Bim Fragment Complex
Volume 108, Issue 6, Pages (March 2002)
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
The TGFβ Receptor Activation Process
Volume 36, Issue 4, Pages (November 2009)
Structure of the TPR Domain of p67phox in Complex with Rac·GTP
Volume 14, Issue 5, Pages (May 2006)
Crystal Structure of Tetrameric Arabidopsis MYC2 Reveals the Mechanism of Enhanced Interaction with DNA  Teng-fei Lian, Yong-ping Xu, Lan-fen Li, Xiao-Dong.
Crystal Structure of the Rab9A-RUTBC2 RBD Complex Reveals the Molecular Basis for the Binding Specificity of Rab9A with RUTBC2  Zhe Zhang, Shanshan Wang,
Volume 111, Issue 3, Pages (November 2002)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Substrate Recognition Mechanism of Atypical Protein Kinase Cs Revealed by the Structure of PKCι in Complex with a Substrate Peptide from Par-3  Chihao.
Volume 108, Issue 1, Pages (January 2002)
Volume 11, Issue 5, Pages (May 2003)
Volume 9, Issue 6, Pages (June 2002)
A Shared Surface of TBP Directs RNA Polymerase II and III Transcription via Association with Different TFIIB Family Members  Xuemei Zhao, Laura Schramm,
Crystal Structure of a Y-Family DNA Polymerase in Action
Volume 20, Issue 1, Pages 9-19 (October 2005)
Volume 106, Issue 6, Pages (September 2001)
Structural Basis of Core Promoter Recognition in a Primitive Eukaryote
Volume 19, Issue 12, Pages (December 2011)
Volume 90, Issue 1, Pages (July 1997)
Structural Basis for Protein Recognition by B30.2/SPRY Domains
Crystal Structure of the TAO2 Kinase Domain
Volume 18, Issue 2, Pages (April 2005)
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 15, Issue 2, Pages (July 2004)
Volume 95, Issue 7, Pages (December 1998)
Volume 13, Issue 4, Pages (October 2015)
Volume 4, Issue 2, Pages (August 1999)
Structural Basis of EZH2 Recognition by EED
Antonina Roll-Mecak, Chune Cao, Thomas E. Dever, Stephen K. Burley 
Structure and Regulation of the CDK5-p25nck5a Complex
Volume 14, Issue 11, Pages (November 2006)
Volume 6, Issue 5, Pages (November 2000)
Heterochromatin Dynamics in Mouse Cells
Volume 9, Issue 12, Pages (December 2001)
Volume 52, Issue 3, Pages (November 2013)
Volume 26, Issue 1, Pages (April 2007)
Volume 85, Issue 5, Pages (May 1996)
Volume 9, Issue 5, Pages (May 2002)
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Jia-Wei Wu, Amy E. Cocina, Jijie Chai, Bruce A. Hay, Yigong Shi 
Caroline M. Groft, Stephen K. Burley  Molecular Cell 
Structure of an IκBα/NF-κB Complex
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Volume 9, Issue 1, Pages (January 2002)
Volume 7, Issue 6, Pages (June 2001)
The Structure of the GGA1-GAT Domain Reveals the Molecular Basis for ARF Binding and Membrane Association of GGAs  Brett M. Collins, Peter J. Watson,
Sabine Pokutta, William I. Weis  Molecular Cell 
Volume 15, Issue 6, Pages (September 2004)
Presentation transcript:

Volume 115, Issue 1, Pages 83-95 (October 2003) The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain  Andrew E.H. Elia, Peter Rellos, Lesley F. Haire, Jerry W. Chao, Frank J. Ivins, Katja Hoepker, Duaa Mohammad, Lewis C. Cantley, Stephen J. Smerdon, Michael B. Yaffe  Cell  Volume 115, Issue 1, Pages 83-95 (October 2003) DOI: 10.1016/S0092-8674(03)00725-6

Figure 1 Mutation of the Plk1 PBD Consensus Motif Defines Specificity Requirements for Phosphopeptide Binding (A) Conservative mutations at the pT-1 serine abolish Plk1 PBD-peptide binding in solution. Isothermal titration calorimetry was used to determine binding affinities. N.D.B. indicates no detectable binding for a Plk1 PBD (residues 326–603) concentration of at least 150 μM. pT denotes phosphothreonine. (B) Binding of GST-Plk1 PBD (residues 326–603) to a filter array of peptide spots, comprising single point mutants of the Plk1 PBD optimal phosphopeptide (right column). Bound GST-Plk1 was detected by blotting with HRP-conjugated anti-GST antibody. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 2 Structure of the Plk1 PBD/Phosphopeptide Complex (A) Defining the boundaries of the PBD by limited proteolysis. Domain architecture of full-length Plk1 and stable fragments (left) are shown together with the time-course of V8 protease digestion (right). Molecular weight and amino acid boundaries of the limiting domain were determined by mass spectroscopy. (B) Superposition of the Polo-box 1 and Polo-box 2 β6α structures, colored as in (A). (C) RIBBONS representation (Carson, 1991) of the structure of the Plk1 PBD in complex with a pThr-containing peptide shown as a ball and stick representation in yellow. The Polo boxes and Polo-cap region are colored as in (A). The phosphopeptide binds at one end of a pocket formed between the two polo boxes. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 3 Details of the Plk1 PBD/Phosphopeptide Interaction (A) Structure-based sequence alignment of the Polo-box domain family. Residues with 100% conservation are shaded purple while highly conserved residues are shaded cyan. (B) The most highly conserved residues within the Plk1 PBD are located exclusively on the peptide binding face of the PBD. The coloring scheme is as in (A). (C) Electrostatic potential of the PBD phosphopeptide pocket, calculated using GRASP (Nicholls et al., 1991), with the phosphopeptide superimposed in stick representation (oxygen atoms, red; nitrogen atoms, blue). Negative potential of the PBD surface is colored red and positive potential blue. (D) Schematic representation of the interactions between the phosphopeptide (blue) and the Plk1 PBD. Hydrogen bonds, van der Waals interactions, and water molecules are denoted by dotted lines, purple crescents, and green circles, respectively. (E) Schematic representation of direct and indirect hydrogen bonds (dotted lines) between the phosphate and the Plk1 PBD. Hydrogen bond lengths are given in angstroms. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 4 Topologies of the Polo Boxes from Plk1 and Sak (A) Comparison of the β sandwich folds of the Plk1 PBD and the Sak Polo-box dimer. Tertiary structures are shown on the top together with secondary structure topology (triangles, β strands; rectangles, α helices) on the bottom. PB1 of Plk1 is colored red while the two Polo boxes of the Sak homodimer are shown in red and blue, respectively. The β6α topology of the Plk1 Polo box is replaced by a circularly permuted β5αβ topology in Sak. Consequently, Plk1 β1 has no equivalent in the Sak Polo-box sequence and instead overlaps structurally with Sak β6. In addition, the Sak β sheet is completed by a “segment-swap” of β4 and 5 between monomers. (B) Sequence alignment of the Polo boxes from Plk1 and Sak. β sheet and α-helix notation follows PB1; the corresponding elements for PB2 are β7 through β12 and αC. A conserved salt-bridging interaction, initially observed in the Sak structural analysis (Leung et al., 2002), is shown by the bracket with the basic and acidic residues highlighted in green. Conserved nonpolar residues are highlighted in blue and residues conserved between Sak and at least one of the Plk1 PBDs are boxed. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 5 Mutation of the H538/K540 Pincer Sequence within the Plk1 PBD Abolishes Phosphopeptide Binding In Vitro and Cdc25 Binding In Vivo (A) Wild-type and mutant Plk1 PBD (residues 326–603) were translated in vitro in the presence of 35S-methionine and examined for binding to an immobilized pThr-Pro-oriented library (pTP) and its unphosphorylated counterpart (TP). (B) H538A/K540M mutation of the Plk1 PBD abolishes binding to its optimal phosphopeptide as measured by isothermal titration calorimetry. (C) Mutation of the H538/K540 pincer disrupts interaction of the isolated Plk1 PBD with Cdc25 in vivo. HeLa cells were transfected with wild-type and mutant versions of a His-Xpress-tagged Plk1 PBD construct (residues 326–603) or with a control Plk1PBD construct lacking the second Polo box (residues 326–506). Cells were arrested in G2/M with nocodazole, the Plk PBD pulled down with NTA beads, and bound endogenous proteins analyzed by SDS-PAGE. Immunoblots revealed preferential association of the PBD with the mitotically hyperphosphorylated form (P) of Cdc25C compared with hypophosphorylated form (U). (D) Mutation of the H538/K540 pincer in the Plk1 PBD disrupts interaction of full-length Plk1 with Cdc25 in vivo. HeLa cells were transfected with wild-type and mutant versions of full-length myc-tagged Plk1 and arrested in G2/M with nocodazole. Plk-myc was immunoprecipitated with anti-myc-conjugated beads and Cdc25 binding to Plk1 analyzed as in (C). (E) Hyper- and hypophosphorylated forms of Cdc25C. Lysates used in (C) and (D), along with a control lysate arrested in G1/S with aphidocolin, were immunoblotted for Cdc25C. (F) Centrosomal localization of the Plk1 PBD in HeLa Cells-U2OS cells were arrested in G2/M with nocodazole and then incubated with wild-type or mutant GST-Plk1 PBD. Overlap of the GST and γ-tubulin signals is shown in the merged panel. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 6 Mutation of the H538/K540 Pincer Prevents G2/M Arrest and Aneuploidy Resulting from Overexpression of the Plk1 PBD in HeLa Cells HeLa cells were transfected with wild-type and mutant GFP-tagged Plk1. Cells were harvested, stained with Hoechst 33342, and analyzed by FACS to determine DNA content in the total cell populations (left images). Similar analysis of the transfected cell population only was performed by gating only on the GFP expressing cells (right images). Percentages are averages from three independent experiments. Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)

Figure 7 Intramolecular Inhibition of the Plk1 Kinase Domain by the PBD Is Relieved by Ligand Binding. (A) Phosphopeptide binding by full-length Plk1 is reduced relative to that for the isolated Plk1 PBD. Approximately 10% of input full-length Plk1 (residues 1–603) interacted with an immobilized pThr-Pro oriented library with slight preference over the unphosphorylated library analog in multiple experiments. The phosphodependent binding component arose from the PBD, as it was eliminated by mutation of the His538/K540M pincer. In contrast, phosphopeptide binding by the isolated PBD (Figure 5A) was 10-fold greater and considerably more phosphodependent. (B) The optimal PBD phosphopeptide stimulates full-length Plk1 kinase activity. GST-Plk1 (prepared in SF9 cells) was preincubated without peptide (closed circles), with 250 μM of the optimal PBD phosphopeptide (open squares) or with 250 μM of the nonphosphorylated optimal peptide counterpart (closed squares) for 5 min at room temperature prior to initiating the kinase reaction by addition of ATP. [32P]-incorporation into casein was determined by SDS-PAGE electrophoresis, autoradiography, and densitometry. (C) The Plk1 kinase domain binds the PBD at a site distinct from the phosphopeptide binding pocket. The kinase domain was translated in vitro in the presence of 35S-methionine and incubated with beads containing wild-type or mutant GST-PBD, or GST alone (bottom image). Bound proteins were analyzed by SDS-PAGE/autoradiography (upper image). (D) A model for Plk1 regulation by the PBD. PB1 and PB2 are shaded orange, kinase domain cyan, phosphopeptide purple with phosphate in red. Inhibitory interactions between the PBD and the kinase domain in the basal state (left) are relieved by phosphopeptide binding (right). Cell 2003 115, 83-95DOI: (10.1016/S0092-8674(03)00725-6)